The Registry of Toxic Effects of Chemical Substances
Arsenic acid, disodium salt, heptahydrate |
UPDATE: November 2004 | MW: 427.00 | MF: AsHO4•2Na•7H2O |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
oral | Drosophila melanogaster
454 ppm
|
SOGEBZ 10,608,1974
|
cytogenetic analysis
|
hamster
embryo
|
10 mg/L
|
ENMUDM 3,597,1981
|
cytogenetic analysis
|
human
leukocyte
|
7,200 nmol/L
|
MUREAV 88,73,1981
|
cytogenetic analysis
|
human
lymphocyte
|
10 mg/L
|
ENMUDM 3,597,1981
|
cytogenetic analysis
|
human
fibroblast
|
16 µmol/L
|
MUREAV 357,123,1996
|
morphological transform
|
human
fibroblast
|
2,500 nmol/L
|
CNREA8 47,3815,1987
|
sister chromatid exchange
|
hamster
embryo
|
1 mg/L
|
ENMUDM 3,597,1981
|
sister chromatid exchange
|
hamster
fibroblast
|
10 mg/L
|
MUREAV 104,141,1982
|
sister chromatid exchange
|
human
lymphocyte
|
5 mg/L
|
ENMUDM 3,597,1981
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | hamster
lowest published toxic dose: 20 mg/kg (8 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
ANEMDG 176,345,1987
|
intraperitoneal | mouse
lowest published toxic dose: 40 mg/kg (9 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Other developmental abnormalities
TJADAB 6,235,1972
|
intraperitoneal | mouse
lowest published toxic dose: 40 mg/kg (9 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Eye, ear Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
NTIS** CONF-771017
|
intraperitoneal | mouse
lowest published toxic dose: 40 mg/kg (9 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetal death Reproductive: Specific developmental abnormalities: Body wall
NTIS** CONF-771017
|
intraperitoneal | mouse
lowest published toxic dose: 45 mg/kg (9 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)
|
AEHLAU 24,62,1972
|
intraperitoneal | mouse
lowest published toxic dose: 45 mg/kg (8 day pregnant)
|
Reproductive: Maternal effects: Uterus, cervix, vagina | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Specific developmental abnormalities: Central nervous system
TCMUD8 22,315,2002
|
intraperitoneal | rat
lowest published toxic dose: 30 mg/kg (9 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
TJADAB 10,153,1974
|
intraperitoneal | rat
lowest published toxic dose: 20 mg/kg (9 day pregnant)
|
Reproductive: Specific developmental abnormalities: Eye, ear | Reproductive: Specific developmental abnormalities: Central nervous system
TJADAB 10,153,1974
|
intraperitoneal | rat
lowest published toxic dose: 20 mg/kg (10 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system | Reproductive: Specific developmental abnormalities: Urogenital system
TJADAB 10,153,1974
|
intraperitoneal | rat
lowest published toxic dose: 35 mg/kg (9 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
TJADAB 60,283,1999
|
intravenous | hamster
lowest published toxic dose: 15 mg/kg (8 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Specific developmental abnormalities: Urogenital system
AEHLAU 22,557,1971
|
intravenous | hamster
lowest published toxic dose: 15 mg/kg (8 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) | Reproductive: Specific developmental abnormalities: Eye, ear
AEHLAU 22,557,1971
|
intravenous | hamster
lowest published toxic dose: 20 mg/kg (8 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system
|
EXMPA6 34,145,1981
|
oral | mouse
lowest published toxic dose: 120 mg/kg (10 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
NTIS** CONF-771017
|
oral | mouse
lowest published toxic dose: 120 mg/kg (10 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetal death
EVHPAZ 19,219,1977
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | mouse
lethal dose (50 percent kill): 87,360 µg/kg
|
N/R
|
EXMDA4 (440),312,1978
|
subcutaneous | guinea pig
lowest published lethal dose: 50 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold Behavioral: Ataxia
BMJOAE 2,217,1913
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 43 mg/kg/4 week- continuous
|
Liver: Other changes | Endocrine: Hypoglycemia Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
JTEHD6 49,177,1996
|
oral | mouse
lowest published toxic dose: 2,520 mg/kg/48 week- continuous
|
Liver: Other changes | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)
TOSCF2 55,460,2000
|
subcutaneous | mouse
lowest published toxic dose: 3,202 mg/kg/15 week- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
TOSCF2 55,460,2000
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.01 mg(As)/m3
|
DTLVS* TLV/BEI,1997
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Confirmed human carcinogen
|
DTLVS* TLV/BEI,1999
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 0.5 mg(As)/m3
|
DTLVS* 3,16,1971
|
Occupational Safety and Health Administration (OSHA)
|
cancer hazard
|
CFRGBR 29,1910.1018,1987
|
Occupational Exposure Limit - ARAB Republic of Egypt
|
time-weighted average 0.2 mg(As)/m3, JAN1993
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 0.05 mg(As)/m3, Carcinogen, JAN1993
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.2 mg(As)/m3, JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.05 mg(As)/m3, JAN1999
|
Occupational Exposure Limit - FINLAND
|
Carcinogen, JAN1993
|
Occupational Exposure Limit - FRANCE
|
VME 0.2 mg(As)/m3, JAN1993
|
Occupational Exposure Limit - HUNGARY
|
short term exposure limit 0.5 mg(As)/m3, Carcinogen, JAN1993
|
Occupational Exposure Limit - INDIA
|
time-weighted average 0.2 mg(As)/m3, JAN1993
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.01 mg(As)/m3, JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 0.5 mg(As)/m3, JAN1993
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 0.3 mg(As)/m3, JAN1999
|
Occupational Exposure Limit - SWEDEN
|
NGV 0.03 mg(As)/m3, Carcinogen, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.1 mg(As)/m3, Carcinogen, JAN1999
|
Occupational Exposure Limit - THAILAND
|
time-weighted average 0.5 mg(As)/m3, JAN1993
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 0.5 mg(As)/m3, JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 0.1 mg(As)/m3, Carcinogen, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Confirmed human carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Confirmed human carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO ARSENIC, INORGANIC-air
|
Carcinogen ceiling concentration 0.002 mg(As)/m3/15 minute
|
NIOSH* DHHS #92-100,1992
|
|
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
NIOSH CURRENT INTELLIGENCE BULLETIN 14, 1976
|
NTP 10th Report on Carcinogens,2002:Known to be a human carcinogen
|
|
REFERENCES:
CODEN
|
|
REFERENCE
AEHLAU
|
Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC
20016) V.1- 1960-
|
ANEMDG
|
Anatomy and Embryology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way,
Secaucus, NJ 07094) V.146- 1974-
|
BMJOAE
|
British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR,
UK) V.1- 1857-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
ENMUDM
|
Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see
EMMUEG.
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
EXMDA4
|
International Congress Series--Excerpta Medica. (Excerpta Medica, Inc., POB 3085, Princeton,
NJ 08540) No.1- 1952-
|
EXMPA6
|
Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1962-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
SOGEBZ
|
Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New
York, NY 10013) V.2- 1966-
|
TCMUD8
|
Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New
York, NY 10003) V.1- 1980-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
|